Abstract
Electroporation is a delivery technique that is gaining popularity among the veterinary community due to its low cost, ease of application, and flexibility. It combines the administration of pharmaceutical compounds such as chemotherapy agents, antisense, and plasmids to the application of permeabilizing pulses. This chapter reviews the veterinary results obtained through the delivery of anticancer drugs (electrochemotherapy) and genes (electro-gene therapy).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Spugnini EP, Fanciulli M, Citro G, Baldi A (2012) Preclinical models in electrochemotherapy: the role of veterinary patients. Future Oncol 8:829–837
Spugnini EP, Renaud SM, Buglioni S et al (2011) Electrochemotherapy with cisplatin enhances local control after surgical ablation of fibrosarcoma in cats: an approach to improve the therapeutic index of highly toxic chemotherapy drugs. J Transl Med 9:152
Benevento R, Santoriello A, Perna G, Canonico S (2012) Electrochemotherapy of cutaneous metastastes from breast cancer in elderly patients: a preliminary report. BMC Surg 12 (Suppl 1):S6
Mali B, Jarm T, Snoj M, Sersa G, Miklavcic D (2013) Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol 39:4–16
Mir LM, Gehl J, Sersa G et al (2006) Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator™ by means of invasive or non-invasive electrodes. Eur J Cancer S4:14–25
Mir LM, Devauchelle P, Quintin-Colonna F et al (1997) First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br J Cancer 76:1617–1622
Kumari R, Li H, Haudenschild DR et al (2012) The oncogene LRF is a survival factor in chondrosarcoma and contributes to tumor malignancy and drug resistance. Carcinogenesis 33: 2076–2083
Folio C, Mora MI, Zalacain M et al (2009) Proteomic analysis of chemonaive pediatric osteosarcomas and corresponding normal bone reveals multiple altered molecular targets. J Proteome Res 8:3882–3888
Walters DK, Steinmann P, Langsam B, Schmutz S, Born W, Fuchs B (2008) Identification of potential chemoresistance genes in osteosarcoma. Anticancer Res 28:673–679
Chou AJ, Gorlick R (2006) Chemotherapy resistance in osteosarcoma: current challenges and future directions. Expert Rev Anticancer Ther 6:1075–1085
Mocellin S, Rossi CR, Brandes A, Nitti D (2006) Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches. Cancer Treat Rev 32:9–27
Tozon N, Sersa G, Cemazar M (2001) Electrochemotherapy: potentiation of local antitumour effectiveness of cisplatin in dogs and cats. Anticancer Res 21:2483–2488
Spugnini EP, Porrello A (2003) Potentiation of chemotherapy in companion animals with spontaneous large neoplasms by application of biphasic electric pulses. J Exp Clin Cancer Res 22:571–580
Spugnini EP, Baldi A, Vincenzi B, Bongiorni F, Bellelli C, Citro G, Porrello A (2007) Intraoperative versus postoperative electrochemotherapy in high grade soft tissue sarcomas: a preliminary study in a spontaneous feline model. Cancer Chemother Pharmacol 59: 375–381
Spugnini EP, Vincenzi B, Citro G et al (2007) Adjuvant electrochemotherapy for the treatment of incompletely excised spontaneous canine sarcomas. In Vivo 21:819–822
Spugnini EP, Dotsinsky I, Mudrov N, Citro G, Caruso G, Cardelli P, Baldi A (2008) Electrochemotherapy-induced radiation recall in a cat. In Vivo 22:751–753
Spugnini EP, Filipponi M, Romani L, Dotsinsky I, Mudrov N, Citro G, Baldi A (2010) Electrochemotherapy treatment for bilateral pleomorphic rhabdomyosarcoma in a cat. J Small Anim Pract 51:330–332
Spugnini EP, Vincenzi B, Betti G et al (2008) Surgery and electrochemotherapy of a high-grade soft tissue sarcoma in a dog. Vet Rec 162: 186–188
Théon AP, Wilson WD, Magdesian KG, Pusterla N, Snyder JR, Galuppo LD (2007) Long-term outcome associated with intratumoral chemotherapy with cisplatin for cutaneous tumors in equidae: 573 cases (1995–2004). J Am Vet Med Assoc 230:1506–1513
Rols MP, Tamzali Y, Teissie J (2002) Electrochemotherapy of horses. A preliminary clinical report. Bioelectrochemistry 55:101–105
Tamzali Y, Teissie J, Rols MP (2001) Cutaneous tumor treatment by electrochemotherapy: preliminary clinical results in horse sarcoids. Revue Méd Vét 152(8–9):605–609
Tamzali Y, Borde L, Rols MP (2012) Successful treatment of equine sarcoids with cisplatin electrochemotherapy: a retrospective study of 48 cases. Equine Vet J 44:214–220
Brockley LK, Cooper MA, Bennett PF (2013) Malignant melanoma in 63 dogs (2001–2011): the effect of carboplatin chemotherapy on survival. N Z Vet J 61:25–31
Dank G, Rassnick KM, Sokolovsky Y et al (2012) Use of adjuvant carboplatin for treatment of dogs with oral malignant melanoma following surgical excision. Vet Comp Oncol 9999. (Epub ahead of print)
Spugnini EP, Dragonetti E, Vincenzi B, Onori N, Citro G, Baldi A (2006) Pulse-mediated chemotherapy enhances local control and survival in a spontaneous canine model of primary mucosal melanoma. Melanoma Res 16:23–27
Spugnini EP, Filipponi M, Romani L et al (2007) Local control and distant metastasis after electrochemotherapy of a canine anal melanoma. In Vivo 21:897–899
Spugnini EP, D’ Alterio GL, Dotsinsky I et al (2011) Electrochemotherapy for the treatment of multiple melanomas in a horse. J Equine Vet Sci 31:430–433
Scacco L, Bolaffio C, Romano A, Fanciulli M, Baldi A, Spugnini EP (2013) Adjuvant electrochemotherapy increases local control in a recurring equine anal melanoma. J Equine Vet Sci 33:637–639
Welle MM, Bley CR, Howard J, Rüfenacht S (2008) Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment. Vet Dermatol 19:321–339
Spugnini EP, Vincenzi B, Baldi F, Citro G, Baldi A (2006) Adjuvant electrochemotherapy for the treatment of incompletely resected canine mast cell tumors. Anticancer Res 26: 4585–4589
Kodre V, Cemazar M, Pecar J, Sersa G, Cor A, Tozon N (2009) Electrochemotherapy compared to surgery for treatment of canine mast cell tumours. In Vivo 23:55–62
Spugnini EP, Vincenzi B, Citro G, Dotsinsky I, Mudrov T, Baldi A (2011) Evaluation of cisplatin as an electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogs. J Vet Intern Med 25:407–411
Spugnini EP, Dotsinsky I, Mudrov N, Citro G, D’Avino A, Baldi A (2008) Biphasic pulses enhance bleomycin efficacy in a spontaneous canine genital tumor model of chemoresistance: sticker sarcoma. J Exp Clin Cancer Res 27:58
Spugnini EP, Citro G, Mellone P, Dotsinsky I, Mudrov N, Baldi A (2007) Electrochemotherapy for localized lymphoma: a preliminary study in companion animals. J Exp Clin Cancer Res 26: 343–346
Tozon N, Kodre V, Sersa G, Cemazar M (2005) Effective treatment of perianal tumors in dogs with electrochemotherapy. Anticancer Res 25:839–845
Spugnini EP, Dotsinsky I, Mudrov N, Cardosi G, Citro G, D’Avino A, Baldi A (2007) Biphasic pulses enhance bleomycin efficacy in a spontaneous canine perianal tumors model. J Exp Clin Cancer Res 26:483–487
Spugnini EP, Dotsinsky I, Mudrov N et al (2008) Adjuvant electrochemotherapy for incompletely excised anal sac carcinoma in a dog. In Vivo 22:47–49
Spugnini EP, Vincenzi B, Citro G, Tonini G, Dotsinsky I, Mudrov N, Baldi A (2009) Electrochemotherapy for the treatment of squamous cell carcinoma in cats: a preliminary report. Vet J 179:117–120
Goodfellow M, Hayes A, Murphy S, Brearley M (2006) A retrospective study of (90)Strontium plesiotherapy for feline squamous cell carcinoma of the nasal planum. J Feline Med Surg 8:169–176
Fidel JL, Egger E, Blattmann H, Oberhänsli F, Kaser-Hotz B (2001) Proton irradiation of feline nasal planum squamous cell carcinomas using an accelerated protocol. Vet Radiol Ultrasound 42:569–575
Spugnini EP (2012) Electroporation enhances bleomycin efficacy in cats with advanced head and neck carcinoma. Proceeding 2nd world vet cancer congress, March 1–3 2012, Paris, France
Spugnini EP, Dotsinsky I, Mudrov N et al (2008) Successful rescue of an apocrine gland carcinoma metastatic to the cervical lymph nodes by mitoxantrone coupled with trains of permeabilizing electrical pulses (electrochemotherapy). In Vivo 22:51–53
Welle MM, Sutter E, Malik Y, Konar M, Rüfenacht S, Howard JE (2009) Fibromatosis in a young Bernese Mountain Dog: clinical, imaging, and histopathological findings. J Vet Diagn Invest 21:895–900
Spugnini EP, Di Tosto G, Salemme S, Pecchia L, Fanciulli M, Baldi A (2013) Electrochemotherapy for the treatment of recurring aponeurotic fibromatosis in a dog. Can Vet J 54:606–609
Smith KC, Neu JC, Krassowska W (2004) Model of creation and evolution of stable electropores for DNA delivery. Biophys J 86: 2813–2826
Draghia-Akli R, Hahn KA, King GK, Cummings K, Carpenter RH (2002) Effects of plasmid mediated growth hormone releasing hormone in severely debilitated dogs with cancer. Mol Ther 6:830–836
Bodles-Brakhop AM, Brown PA, Pope MA, Draghia-Akli R (2008) Double-blinded, Placebo-controlled Plasmid GHRH Trial for Cancer-associated Anemia in Dogs. Mol Ther 16:862–870
Li S, Reed SD (2009) Electroporation advances in large animals. Curr Gene Ther 9:316–326
Reed SD, Fulmer A, Buckholz J, Zhang B, Cutrera J, Shiomitsu K, Li S (2010) Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs. Cancer Gene Ther 17: 457–464
Pavlin D, Cemazar M, Cör A, Sersa G, Pogacnik A, Tozon N (2011) Electrogene therapy with interleukin-12 in canine mast cell tumors. Radiol Oncol 45:31–39
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Spugnini, E.P., Baldi, A. (2014). Electrochemotherapy in Veterinary Oncology: From Rescue to First Line Therapy. In: Li, S., Cutrera, J., Heller, R., Teissie, J. (eds) Electroporation Protocols. Methods in Molecular Biology, vol 1121. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-9632-8_22
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9632-8_22
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4614-9631-1
Online ISBN: 978-1-4614-9632-8
eBook Packages: Springer Protocols